REDUCTION OF SERUM THEOPHYLLINE LEVELS BY TERBUTALINE IN CHILDREN WITH ASTHMA

被引:26
作者
DANZIGER, Y
GARTY, M
VOLWITZ, B
ILFELD, D
VARSANO, I
ROSENFELD, JB
机构
[1] BEILINSON MED CTR,DEPT MED C,IL-49100 PETACH TIKVA,ISRAEL
[2] TEL AVIV UNIV,SACKLER SCH MED,TEL AVIV,ISRAEL
[3] BEILINSON MED CTR,DEPT PEDIAT B,CLIN PHARMACOL UNIT,IL-49100 PETACH TIKVA,ISRAEL
关键词
D O I
10.1038/clpt.1985.73
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:469 / 471
页数:3
相关论文
共 12 条
[1]  
BARCLAY J, 1981, LANCET, V2, P369
[2]   EFFECTS OF METOPROLOL AND PROPRANOLOL ON THEOPHYLLINE ELIMINATION [J].
CONRAD, KA ;
NYMAN, DW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) :463-467
[3]   EFFECTS OF ORAL THEOPHYLLINE AND ORAL SALBUTAMOL IN THE TREATMENT OF ASTHMA [J].
DAWSON, KP ;
FERGUSSON, DM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1982, 57 (09) :674-676
[4]   A CRITIQUE OF DOSING STRATEGIES FOR BETA-2 ADRENERGIC AGENTS AND THEOPHYLLINE [J].
JENNE, JW .
LUNG, 1981, 159 (06) :295-314
[5]   COMBINED TREATMENT WITH SUSTAINED-RELEASE THEOPHYLLINE AND BETA2-ADRENOCEPTOR-STIMULATING AGENTS IN CHRONIC CHILDHOOD ASTHMA [J].
LONNERHOLM, G ;
FOUCARD, T ;
LINDSTROM, B .
BRITISH MEDICAL JOURNAL, 1981, 282 (6269) :1029-1031
[6]  
MADSEN SM, 1981, ACTA PHARMACOL TOX, V48, P13
[7]   A PRACTICAL GUIDE TO INTERACTIONS INVOLVING THEOPHYLLINE KINETICS [J].
MCELNAY, JC ;
SMITH, GD ;
HELLING, DK .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (7-8) :533-542
[8]  
ORCUTT JJ, 1977, CLIN CHEM, V23, P599
[9]   DOSAGE OF THEOPHYLLINE IN BRONCHIAL-ASTHMA [J].
PIAFSKY, KM ;
OGILVIE, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (23) :1218-1222
[10]  
RODDICK LG, 1979, MED J AUSTRALIA, V118, P153